Glomerulonephritis

62 Glomerulonephritis



Glomerulonephritis (GN) is a term used to describe an inflammatory insult to the kidney’s glomeruli. A clinical pattern of hematuria, proteinuria, hypertension, red blood cell (RBC) casts, azotemia, oligoanuria, and edema occurs in various combinations. The inciting process varies from infectious to immunologic and from autoimmune to hereditary. Prompt recognition of GN is important because this disease can result in hypertensive emergency, hyperkalemia, heart failure, pulmonary edema, and renal failure. In addition, early diagnosis of GN permits prompt medical treatment of destructive subtypes that can cause long-term renal damage. Supportive care consists of strict attention to fluid and electrolyte management and blood pressure control. Certain types of GN require specific medical management to combat renal inflammation. An understanding of the diagnosis and management of GN ensures the best chance at reducing immediate morbidity and mortality as well as reducing the likelihood of progression to chronic kidney disease (CKD).




Differential Diagnosis


The two most common causes of GN in children are acute postinfectious GN (APIGN) and IgA nephropathy (IgAN). Other less common but important causes of GN include Henoch-Schönlein purpura (HSP), membranoproliferative GN (MPGN), rapidly progressive GN (RPGN), antineutrophilic cytoplasmic antibody– (ANCA-) positive vasculitis, systemic lupus erythematosus (SLE), and hemolytic-uremic syndrome (HUS).





Henoch-Schönlein Purpura Nephritis


HSP nephritis is a small vessel vasculitis caused by IgA deposition within the glomeruli in the context of systemic HSP. Renal manifestations may present weeks after the onset of systemic HSP; rarely is it the first feature manifested in this syndrome. Prevalence of renal manifestations is subject to observer bias. Pediatric nephrology centers report that 50% of children with HSPN have hematuria and proteinuria, 8% have acute GN (AGN), 13% have nephrotic syndrome, and 29% have a mixed nephritic and nephrotic syndrome. Treatment of HSP nephritis is controversial because of a high rate of spontaneous remission and the lack of rigorous studies regarding treatment. Prognostic features are noted in Table 62-1.


Table 62-1 Poor Prognostic Features of Selected Glomerulonephritides and Recommended Treatment



























Disease Poor Prognostic Features First-Line Treatment
IgAN Proteinuria >1 g/24 h, hypertension, azotemia, interstitial fibrosis, sclerotic glomeruli If medical treatment,- corticosteroid ACEI
HSP Presence of nephritic or nephrotic syndrome, renal failure, nephrotic-range ongoing proteinuria, interstitial fibrosis, sclerotic glomeruli If medical treatment needed, corticosteroids, immunosuppressive agents
SLE Diffuse proliferative GN (WHO Class IV), ↑ creatinine, persistent HTN, chronic anemia, nephrotic-range proteinuria Corticosteroid therapy, cyclophosphamide, azathioprine, MMF
ANCA+ vasculitis or pauci-immune GN Crescents on biopsy, frequent relapses Corticosteroid therapy, azathioprine, MMF, cyclophosphamide
MPGN Type II disease, nephrotic-range proteinuria Corticosteroid therapy

ANCA, antineutrophilic cytoplasmic antibody; AZA, azathioprine; CCS, corticosteroids; GN, glomerulonephritis; HSP, Henoch-Schönlein purpura; HTN, hypertension; IgAN, IgA nephropathy; MMF, mycophenolate mofetil; MPGN, membranoproliferative glomerulonephritis; SLE, systemic lupus erythematosus; WHO, World Health Organization.

< div class='tao-gold-member'>

Stay updated, free articles. Join our Telegram channel

Jun 19, 2016 | Posted by in PEDIATRICS | Comments Off on Glomerulonephritis

Full access? Get Clinical Tree

Get Clinical Tree app for offline access